{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T20:37:36Z","timestamp":1773693456007,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the \"1-3-5\" Project for Disciplines of Excellence, West China Hospital, Sichuan University","award":["ZYJC21030"],"award-info":[{"award-number":["ZYJC21030"]}]},{"DOI":"10.13039\/100012542","name":"Sichuan Provincial Science and Technology Support Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Supported by the Sichuan Science and Technology Program"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"DOI":"10.1186\/s12916-025-04358-7","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T15:36:29Z","timestamp":1756740989000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Proteomics and metabolomics studies in pigmented villonodular synovitis uncover the regulation of monocyte differentiation by the ADGRE5-NF-\u03baB pathway"],"prefix":"10.1186","volume":"23","author":[{"given":"Minghao","family":"Ge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Runze","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baojun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maosen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianhao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weili","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,1]]},"reference":[{"key":"4358_CR1","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ejca.2016.04.022","volume":"63","author":"EL Staals","year":"2016","unstructured":"Staals EL, Ferrari S, Donati DM, Palmerini E. Diffuse-type tenosynovial giant cell tumour: current treatment concepts and future perspectives. Eur J Cancer. 2016;63:34\u201340.","journal-title":"Eur J Cancer"},{"key":"4358_CR2","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00256-006-0249-3","volume":"36","author":"BP Rubin","year":"2007","unstructured":"Rubin BP. Tenosynovial giant cell tumor and pigmented villonodular synovitis: a proposal for unification of these clinically distinct but histologically and genetically identical lesions. Skelet Radiol. 2007;36:267\u20138.","journal-title":"Skelet Radiol"},{"key":"4358_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/art.42946","author":"T Li","year":"2024","unstructured":"Li T, Xiong Y, Li J, Tang X, Zhong Y, Tang Z, et al. Mapping and analysis of protein and gene profile identification of the important role of transforming growth factor beta in synovial invasion in patients with pigmented villonodular synovitis. Arthritis Rheumatol. 2024. https:\/\/doi.org\/10.1002\/art.42946.","journal-title":"Arthritis Rheumatol"},{"key":"4358_CR4","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1097\/PAS.0b013e31802b86f8","volume":"31","author":"JS Cupp","year":"2007","unstructured":"Cupp JS, Miller MA, Montgomery KD, Nielsen TO, O\u2019Connell JX, Huntsman D, et al. Translocation and expression of CSF1 in pigmented villonodular synovitis, tenosynovial giant cell tumor, rheumatoid arthritis and other reactive synovitides. Am J Surg Pathol. 2007;31:970\u20136.","journal-title":"Am J Surg Pathol"},{"key":"4358_CR5","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.autrev.2010.07.001","volume":"9","author":"U Fiocco","year":"2010","unstructured":"Fiocco U, Sfriso P, Lunardi F, Pagnin E, Oliviero F, Scagliori E, et al. Molecular pathways involved in synovial cell inflammation and tumoral proliferation in diffuse pigmented villonodular synovitis. Autoimmun Rev. 2010;9:780\u20134.","journal-title":"Autoimmun Rev"},{"key":"4358_CR6","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1055\/s-2001-16925","volume":"139","author":"M Neu\u00df","year":"2001","unstructured":"Neu\u00df M, Hermanns B, Wirtz D. Rezidiv einer pigmentierten villo-nodul\u00e4ren Synovialitis (PVNS). Z Orthop Ihre Grenzgeb. 2001;139:366\u20139.","journal-title":"Z Orthop Ihre Grenzgeb"},{"key":"4358_CR7","doi-asserted-by":"publisher","first-page":"E656","DOI":"10.1097\/BRS.0b013e31817eb85a","volume":"33","author":"J Rovner","year":"2008","unstructured":"Rovner J, Yaghoobian A, Gott M, Tindel N. Pigmented villonodular synovitis of the zygoapophyseal joint: a case report. Spine (Phila Pa 1976). 2008;33:E656-658.","journal-title":"Spine (Phila Pa 1976)"},{"key":"4358_CR8","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1200\/JCO.2017.75.8482","volume":"36","author":"MM Gounder","year":"2018","unstructured":"Gounder MM, Thomas DM, Tap WD. Locally aggressive connective tissue tumors. J Clin Oncol. 2018;36:202\u20139.","journal-title":"J Clin Oncol"},{"key":"4358_CR9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11912-020-00926-7","volume":"22","author":"NM Bernthal","year":"2020","unstructured":"Bernthal NM, Ishmael CR, Burke ZDC. Management of pigmented villonodular synovitis (PVNS): an orthopedic surgeon\u2019s perspective. Curr Oncol Rep. 2020;22:63.","journal-title":"Curr Oncol Rep"},{"key":"4358_CR10","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s11999-012-2589-8","volume":"471","author":"MW Colman","year":"2013","unstructured":"Colman MW, Ye J, Weiss KR, Goodman MA, McGough RL. Does combined open and arthroscopic synovectomy for diffuse PVNS of the knee improve recurrence rates? Clin Orthop Relat Res. 2013;471:883\u201390.","journal-title":"Clin Orthop Relat Res"},{"key":"4358_CR11","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1302\/0301-620X.97B4.34907","volume":"97-B","author":"B Mollon","year":"2015","unstructured":"Mollon B, Lee A, Busse JW, Griffin AM, Ferguson PC, Wunder JS, et al. The effect of surgical synovectomy and radiotherapy on the rate of recurrence of pigmented villonodular synovitis of the knee: an individual patient meta-analysis. Bone Joint J. 2015;97-B:550\u20137.","journal-title":"Bone Joint J"},{"key":"4358_CR12","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.arthro.2014.04.101","volume":"30","author":"J-C Aur\u00e9gan","year":"2014","unstructured":"Aur\u00e9gan J-C, Klouche S, Bohu Y, Lef\u00e8vre N, Herman S, Hardy P. Treatment of Pigmented Villonodular Synovitis of the Knee. Arthroscopy: J Arthro Rel Surg. 2014;30:1327\u201341.","journal-title":"Arthroscopy: J Arthro Rel Surg"},{"key":"4358_CR13","doi-asserted-by":"publisher","first-page":"10573","DOI":"10.7150\/thno.48666","volume":"10","author":"C Cao","year":"2020","unstructured":"Cao C, Wu F, Niu X, Hu X, Cheng J, Zhang Y, et al. Cadherin-11 cooperates with inflammatory factors to promote the migration and invasion of fibroblast-like synoviocytes in pigmented villonodular synovitis. Theranostics. 2020;10:10573\u201388.","journal-title":"Theranostics"},{"key":"4358_CR14","doi-asserted-by":"publisher","first-page":"665442","DOI":"10.3389\/fimmu.2021.665442","volume":"12","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Lv J, Zhang H, Xie J, Dai H, Zhang X. Gene expression profiles analyzed using integrating RNA sequencing, and microarray reveals increased inflammatory response, proliferation, and osteoclastogenesis in pigmented villonodular synovitis. Front Immunol. 2021;12: 665442.","journal-title":"Front Immunol"},{"key":"4358_CR15","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1073\/pnas.0507321103","volume":"103","author":"RB West","year":"2006","unstructured":"West RB, Rubin BP, Miller MA, Subramanian S, Kaygusuz G, Montgomery K, et al. A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells. Proc Natl Acad Sci U S A. 2006;103:690\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4358_CR16","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1136\/annrheumdis-2021-222021","volume":"81","author":"T N\u00e9meth","year":"2022","unstructured":"N\u00e9meth T, Nagy G, Pap T. Synovial fibroblasts as potential drug targets in rheumatoid arthritis, where do we stand and where shall we go? Ann Rheum Dis. 2022;81:1055\u201364.","journal-title":"Ann Rheum Dis"},{"key":"4358_CR17","first-page":"e56215","volume":"16","author":"W Abed Alharbi","year":"2024","unstructured":"Abed Alharbi W, Mohammed Alshareef H, Hennawi YB, Munshi AA, Khalid AA. Giant cell tumor in tarsal midfoot bones: a case report. Cureus. 2024;16: e56215.","journal-title":"Cureus"},{"key":"4358_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","volume":"23","author":"NN Pavlova","year":"2016","unstructured":"Pavlova NN, Thompson CB. The emerging hallmarks of cancer metabolism. Cell Metab. 2016;23:27\u201347.","journal-title":"Cell Metab"},{"key":"4358_CR19","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.cmet.2022.01.007","volume":"34","author":"NN Pavlova","year":"2022","unstructured":"Pavlova NN, Zhu J, Thompson CB. The hallmarks of cancer metabolism: still emerging. Cell Metab. 2022;34:355\u201377.","journal-title":"Cell Metab"},{"key":"4358_CR20","doi-asserted-by":"publisher","first-page":"e248\u2013e248","DOI":"10.1038\/cddis.2011.123","volume":"3","author":"C Mu\u00f1oz-Pinedo","year":"2012","unstructured":"Mu\u00f1oz-Pinedo C, El Mjiyad N, Ricci J-E. Cancer metabolism: current perspectives and future directions. Cell Death Dis. 2012;3: e248\u2013e248.","journal-title":"Cell Death Dis"},{"key":"4358_CR21","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1136\/ard.38.5.463","volume":"38","author":"B Henderson","year":"1979","unstructured":"Henderson B, Bitensky L, Johnstone JJ, Catterall A, Chayen J. Metabolic alterations in human synovial lining cells in pigmented villonodular synovitis. Ann Rheum Dis. 1979;38:463\u20136.","journal-title":"Ann Rheum Dis"},{"key":"4358_CR22","doi-asserted-by":"publisher","first-page":"105664","DOI":"10.1016\/j.ebiom.2025.105664","volume":"114","author":"J Yan","year":"2025","unstructured":"Yan J, Han VX, Jones HF, Couttas TA, Jieu B, Leweke FM, et al. Cerebrospinal fluid metabolomics in autistic regression reveals dysregulation of sphingolipids and decreased \u03b2-hydroxybutyrate. EBioMedicine. 2025;114: 105664.","journal-title":"EBioMedicine"},{"key":"4358_CR23","doi-asserted-by":"crossref","unstructured":"Li L, Li R, Qiu Z, Zhu K, Li R, Zhao S, et al. Prediction of Weight Loss and Regain Based on Multiomic and Phenotypic Features: Results From a Calorie-Restricted Feeding Trial. Diabetes Care. 2025;dc250728.","DOI":"10.2337\/dc25-0728"},{"key":"4358_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03715-6","author":"N Miglino","year":"2025","unstructured":"Miglino N, Toussaint NC, Ring A, Bonilla X, Tusup M, Gosztonyi B, et al. Feasibility of multiomics tumor profiling for guiding treatment of melanoma. Nat Med. 2025. https:\/\/doi.org\/10.1038\/s41591-025-03715-6.","journal-title":"Nat Med"},{"key":"4358_CR25","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/cns.13657","volume":"27","author":"M-H Ge","year":"2021","unstructured":"Ge M-H, Tian H, Mao L, Li D-Y, Lin J-Q, Hu H-S, et al. Zinc attenuates ferroptosis and promotes functional recovery in contusion spinal cord injury by activating Nrf2\/GPX4 defense pathway. CNS Neurosci Ther. 2021;27:1023\u201340.","journal-title":"CNS Neurosci Ther"},{"key":"4358_CR26","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1097\/CORR.0000000000002934","volume":"482","author":"L Yao","year":"2024","unstructured":"Yao L, Li Y, Li T, Fu W, Chen G, Li Q, et al. What are the recurrence rates, complications, and functional outcomes after multiportal arthroscopic synovectomy for patients with knee diffuse-type tenosynovial giant-cell tumors? Clin Orthop Relat Res. 2024;482:1218\u201329.","journal-title":"Clin Orthop Relat Res"},{"key":"4358_CR27","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1002\/jso.27067","volume":"126","author":"NM Bernthal","year":"2022","unstructured":"Bernthal NM, Healey JH, Palmerini E, Bauer S, Schreuder H, Leithner A, et al. A prospective real-world study of the diffuse-type tenosynovial giant cell tumor patient journey: a 2-year observational analysis. J Surg Oncol. 2022;126:1520\u201332.","journal-title":"J Surg Oncol"},{"key":"4358_CR28","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1136\/ard.2004.025445","volume":"64","author":"K Ijiri","year":"2005","unstructured":"Ijiri K, Tsuruga H, Sakakima H, Tomita K, Taniguchi N, Shimoonoda K, et al. Increased expression of humanin peptide in diffuse-type pigmented villonodular synovitis: implication of its mitochondrial abnormality. Ann Rheum Dis. 2005;64:816.","journal-title":"Ann Rheum Dis"},{"key":"4358_CR29","doi-asserted-by":"publisher","first-page":"e1547","DOI":"10.1016\/j.eats.2017.06.029","volume":"6","author":"JS Chang","year":"2017","unstructured":"Chang JS, Higgins JP, Kosy JD, Theodoropoulos J. Systematic arthroscopic treatment of diffuse pigmented villonodular synovitis in the knee. Arthrosc Tech. 2017;6:e1547-51.","journal-title":"Arthrosc Tech"},{"key":"4358_CR30","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1136\/ard.61.6.493","volume":"61","author":"A Swan","year":"2002","unstructured":"Swan A, Amer H, Dieppe P. The value of synovial fluid assays in the diagnosis of joint disease: a literature survey. Ann Rheum Dis. 2002;61:493\u20138.","journal-title":"Ann Rheum Dis"},{"key":"4358_CR31","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/10408363.2017.1408561","volume":"54","author":"SM Mahendran","year":"2017","unstructured":"Mahendran SM, Oikonomopoulou K, Diamandis EP, Chandran V. Synovial fluid proteomics in the pursuit of arthritis mediators: an evolving field of novel biomarker discovery. Crit Rev Clin Lab Sci. 2017;54:495\u2013505.","journal-title":"Crit Rev Clin Lab Sci"},{"key":"4358_CR32","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/0046-8177(94)90254-2","volume":"25","author":"JM Darling","year":"1994","unstructured":"Darling JM, Glimcher LH, Shortkroff S, Albano B, Gravallese EM. Expression of metalloproteinases in pigmented villonodular synovitis. Hum Pathol. 1994;25:825\u201330.","journal-title":"Hum Pathol"},{"key":"4358_CR33","first-page":"110","volume":"31","author":"M Uchibori","year":"2004","unstructured":"Uchibori M, Nishida Y, Tabata I, Sugiura H, Nakashima H, Yamada Y, et al. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in pigmented villonodular synovitis suggests their potential role for joint destruction. J Rheumatol. 2004;31:110\u20139.","journal-title":"J Rheumatol"},{"key":"4358_CR34","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.apsb.2019.01.015","volume":"9","author":"F Zhou","year":"2019","unstructured":"Zhou F, Mei J, Han X, Li H, Yang S, Wang M, et al. Kinsenoside attenuates osteoarthritis by repolarizing macrophages through inactivating NF-\u03baB\/MAPK signaling and protecting chondrocytes. Acta Pharm Sin B. 2019;9:973\u201385.","journal-title":"Acta Pharm Sin B"},{"key":"4358_CR35","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1136\/annrheumdis-2019-215696","volume":"79","author":"L Kuang","year":"2020","unstructured":"Kuang L, Wu J, Su N, Qi H, Chen H, Zhou S, et al. Fgfr3 deficiency enhances CXCL12-dependent chemotaxis of macrophages via upregulating CXCR7 and aggravates joint destruction in mice. Ann Rheum Dis. 2020;79:112\u201322.","journal-title":"Ann Rheum Dis"},{"issue":"25","key":"4358_CR36","first-page":"00268","volume":"S1550\u20134131","author":"M Shan","year":"2025","unstructured":"Shan M, Zhang S, Luo Z, Deng S, Ran L, Zhou Q, et al. Itaconate promotes inflammatory responses in tissue-resident alveolar macrophages and exacerbates acute lung injury. Cell Metab. 2025;S1550\u20134131(25):00268\u201372.","journal-title":"Cell Metab"},{"key":"4358_CR37","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41413-025-00437-w","volume":"13","author":"K Rong","year":"2025","unstructured":"Rong K, Wang D, Pu X, Zhang C, Zhang P, Cao X, et al. Inflammatory macrophage-derived itaconate inhibits DNA demethylase TET2 to prevent excessive osteoclast activation in rheumatoid arthritis. Bone Res. 2025;13: 60.","journal-title":"Bone Res"},{"key":"4358_CR38","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1136\/ard-2023-224774","volume":"83","author":"K Kachler","year":"2024","unstructured":"Kachler K, Andreev D, Thapa S, Royzman D, Gie\u00dfl A, Karuppusamy S, et al. Acod1-mediated inhibition of aerobic glycolysis suppresses osteoclast differentiation and attenuates bone erosion in arthritis. Ann Rheum Dis. 2024;83:1691\u2013706.","journal-title":"Ann Rheum Dis"},{"key":"4358_CR39","doi-asserted-by":"publisher","first-page":"101113","DOI":"10.1016\/j.plipres.2021.101113","volume":"83","author":"M Abshirini","year":"2021","unstructured":"Abshirini M, Ilesanmi-Oyelere BL, Kruger MC. Potential modulatory mechanisms of action by long-chain polyunsaturated fatty acids on bone cell and chondrocyte metabolism. Prog Lipid Res. 2021;83: 101113.","journal-title":"Prog Lipid Res"},{"key":"4358_CR40","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41413-024-00389-7","volume":"13","author":"Y You","year":"2025","unstructured":"You Y, Huo K, He L, Wang T, Zhao L, Li R, et al. GnIH secreted by green light exposure, regulates bone mass through the activation of Gpr147. Bone Res. 2025;13:13.","journal-title":"Bone Res"},{"key":"4358_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/art.43242","author":"M Lesturgie-Talarek","year":"2025","unstructured":"Lesturgie-Talarek M, Gonzalez V, Beaudoin L, S\u00e9not N, Miceli-Richard C, Allanore Y, et al. Mucosal-associated invariant T cells in rheumatic diseases. Arthritis Rheumatol. 2025. https:\/\/doi.org\/10.1002\/art.43242.","journal-title":"Arthritis Rheumatol"},{"key":"4358_CR42","doi-asserted-by":"publisher","first-page":"eabm9843","DOI":"10.1126\/sciadv.abm9843","volume":"11","author":"S Ray","year":"2025","unstructured":"Ray S, McCall JL, Tian JB, Jeon J, Douglas A, Tyler K, et al. Targeting TRPC channels for control of arthritis-induced bone erosion. Sci Adv. 2025;11: eabm9843.","journal-title":"Sci Adv"},{"key":"4358_CR43","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1016\/j.apsb.2025.02.031","volume":"15","author":"C Han","year":"2025","unstructured":"Han C, Jiang L, Wang W, Zuo S, Gu J, Chen L, et al. GRK2 activates TRAF2-NF-\u03baB signalling to promote hyperproliferation of fibroblast-like synoviocytes in rheumatoid arthritis. Acta Pharm Sin B. 2025;15:1956\u201373.","journal-title":"Acta Pharm Sin B"},{"key":"4358_CR44","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41419-021-04455-4","volume":"13","author":"R Li","year":"2022","unstructured":"Li R, Guan Z, Bi S, Wang F, He L, Niu X, et al. The proton-activated G protein-coupled receptor GPR4 regulates the development of osteoarthritis via modulating CXCL12\/CXCR7 signaling. Cell Death Dis. 2022;13: 152.","journal-title":"Cell Death Dis"},{"key":"4358_CR45","doi-asserted-by":"publisher","first-page":"105105","DOI":"10.1016\/j.jbc.2023.105105","volume":"299","author":"TI Slepak","year":"2023","unstructured":"Slepak TI, Guyot M, Walters W, Eichberg DG, Ivan ME. Dual role of the adhesion G-protein coupled receptor ADRGE5\/CD97 in glioblastoma invasion and proliferation. J Biol Chem. 2023;299: 105105.","journal-title":"J Biol Chem"},{"key":"4358_CR46","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1038\/s41423-023-01103-z","volume":"20","author":"H Chang","year":"2023","unstructured":"Chang H, Hou P, Wang X, Xiang A, Wu H, Qi W, et al. CD97 negatively regulates the innate immune response against RNA viruses by promoting RNF125-mediated RIG-I degradation. Cell Mol Immunol. 2023;20:1457\u201371.","journal-title":"Cell Mol Immunol"},{"key":"4358_CR47","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1124\/pr.119.018044","volume":"71","author":"HA Dunn","year":"2019","unstructured":"Dunn HA, Orlandi C, Martemyanov KA. Beyond the ligand: extracellular and transcellular G protein-coupled receptor complexes in physiology and pharmacology. Pharmacol Rev. 2019;71:503\u201319.","journal-title":"Pharmacol Rev"},{"key":"4358_CR48","doi-asserted-by":"publisher","first-page":"4878","DOI":"10.1111\/febs.13027","volume":"281","author":"C-C Hsiao","year":"2014","unstructured":"Hsiao C-C, Wang W-C, Kuo W-L, Chen H-Y, Chen T-C, Hamann J, et al. CD97 inhibits cell migration in human fibrosarcoma cells by modulating TIMP-2\/MT1- MMP\/MMP-2 activity\u2013role of GPS autoproteolysis and functional cooperation between the N- and C-terminal fragments. FEBS J. 2014;281:4878\u201391.","journal-title":"FEBS J"},{"key":"4358_CR49","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.neo.2018.12.005","volume":"21","author":"GB Park","year":"2019","unstructured":"Park GB, Kim D. Microrna-503-5p inhibits the CD97-mediated JAK2\/STAT3 pathway in metastatic or paclitaxel-resistant ovarian cancer cells. Neoplasia. 2019;21:206\u201315.","journal-title":"Neoplasia"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-04358-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-025-04358-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-04358-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T11:20:55Z","timestamp":1756898455000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-025-04358-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4358"],"URL":"https:\/\/doi.org\/10.1186\/s12916-025-04358-7","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,1]]},"assertion":[{"value":"8 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study received approval from the Ethics Committee on Biomedical Research at West China Hospital, Sichuan University (No. 125 2020-(921)). Informed consent was obtained from all participants before their involvement in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate."}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"513"}}